Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency SyndromeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether the enteric virome, alongside the bacterial microbiome, contributes to HIV-associated immunodeficiency and gut disease. Researchers characterized viral and bacterial communities in stool to see how they relate to HIV infection, antiretroviral therapy (ART) status, and CD4 T cell counts. The goal was to determine whether virome alterations track with immune decline independent of treatment.
Who was studied?
The cohort consisted of Ugandan patients, including individuals without HIV infection and individuals with HIV infection who were either on ART or untreated. The abstract does not give an exact sample size or additional demographic detail. Findings are grouped by HIV status, treatment status, and peripheral CD4 T cell count level.
What were the most important findings?
Low peripheral CD4 T cell counts were associated with an expansion of enteric adenovirus sequences, and this pattern held regardless of ART treatment. Patients with lower CD4 counts also had a bacterial microbiome with reduced phylogenetic diversity and richness. Specific bacterial taxa showed differential abundance, notably an increase in Enterobacteriaceae, a group linked to inflammation.
What are the greatest implications of this study?
The findings suggest that immunodeficiency in progressive HIV infection is accompanied by coordinated shifts in both the enteric virome and bacterial microbiome, not bacterial changes alone. Because the adenovirus expansion occurred regardless of ART status, viral alterations may persist even in treated patients and could still contribute to gut dysfunction. These combined viral and bacterial changes may help drive AIDS-associated enteropathy and disease progression, pointing to the virome as an underexplored factor in HIV-related gut pathology.